CIK: 0001634557
申报总市值
—
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | 股票-医疗保健 | 33.91% | — | +5.36% | |
| 2 | REYN | Reynolds Consumer Products Inc. | 股票-其他 | 23.62% | — | -38.65% | |
| 3 | PRTA | Prothena Corporation plc | 股票-其他 | 16.93% | — | +10.85% | |
| 4 | ALKS | Alkermes plc | 股票-医疗保健 | 15.30% | — | +5.67% | |
| 5 | TBPH | Theravance Biopharma, Inc. | 股票-其他 | 9.31% | -71.30% | EXIT | |
| 6 | NWBO | Northwest Biotherapeutics | 股票-其他 | 0.71% | — | — | |
| 7 | BIIB | Biogen INC | 股票-医疗保健 | 0.23% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | +5% | +5.36% | 加仓 |
| 2 | ALKS | Alkermes plc | +4.2% | +5.67% | 加仓 |
| 3 | TBPH | Theravance Biopharma, Inc. | +3.5% | +27.97% | 加仓 |
| 4 | PRTA | Prothena Corporation plc | -0.6% | +10.85% | 加仓 |
| 5 | NWBO | Northwest Biotherapeutics | -1% | — | 不变 |
| 6 | REYN | Reynolds Consumer Products Inc. | -11.3% | -38.65% | 减仓 |
| 7 | BIIB | Biogen INC | — | NEW | 新建仓 |